MedSina
Health library › Evidence-based

Understanding Systemic Lupus Erythematosus (SLE)

October 3, 2026·5 min read ·MedSina Evidence · PubMed

Systemic lupus erythematosus (SLE) is a complex autoimmune disease where the body's immune system mistakenly attacks its own tissues, leading to inflammation and damage in various organs.

Understanding Systemic Lupus Erythematosus (SLE)

What is Systemic Lupus Erythematosus (SLE)?

Systemic lupus erythematosus (SLE) is a chronic, life-threatening inflammatory condition that affects multiple body systems [1]. It is classified as an autoimmune disease, meaning the body's immune system, which normally protects against infections, mistakenly targets and attacks its own healthy tissues as if they were foreign invaders [6]. This widespread attack can lead to inflammation and damage in various organs throughout the body [1].

SLE most commonly affects the skin, joints, and kidneys, but it has the potential to impact almost any part of the body, including the eyes, heart, and liver [1, 2, 8]. While SLE can affect anyone, it predominantly presents in women, often during puberty or early adulthood, showing a definitive female predilection [2, 6]. The reported increase in the incidence of SLE over time is largely attributed to a greater awareness of the disease and the development of advanced serological detection methods, rather than a change in the disease's severity or expression [3].

Recognizing the Signs: Diagnosis of SLE

Diagnosing systemic lupus erythematosus can be challenging because its symptoms often overlap with those of other common conditions [7]. There is no single test for SLE; instead, diagnosis relies on a careful evaluation of a combination of characteristic symptoms, physical signs, and specific laboratory findings, while also ruling out other potential diagnoses [6]. Recent years have seen updates to the diagnostic criteria for SLE, aiming to improve accuracy [1].

Healthcare providers, including obstetrician-gynecologists (ob-gyns), often play a crucial role in the early identification of SLE. An ob-gyn may be the first physician to notice common SLE-related indicators such as a distinctive rash, swollen joints, low blood cell counts (cytopenias), or protein in the urine (proteinuria) [2]. Diagnostic evaluation typically includes blood tests to detect specific autoantibodies, such as antinuclear antibodies (ANA), which are hallmarks of autoimmune diseases [3]. Researchers are also exploring novel molecular biomarkers that could aid in earlier diagnosis and help categorize the disease more precisely [1].

In some cases, SLE can present with less common initial manifestations, making diagnosis even more complex. For example, severe liver dysfunction or a large fluid accumulation around the lungs (unilateral pleural effusion) can sometimes be the very first signs of SLE in adults [7, 8]. Differentiating liver injury caused by SLE from other conditions like autoimmune hepatitis can be particularly difficult based on tissue examination alone [8].

How SLE Affects the Body

As a multisystem disease, SLE can manifest in diverse ways across the body:

Managing Systemic Lupus Erythematosus

The management of SLE is multifaceted and aims to control inflammation, prevent organ damage, and alleviate symptoms [2]. Treatment plans are highly individualized, taking into account the specific organs affected and the severity of the disease. Established and novel therapeutic agents are used, and ongoing research continues to explore new options [1].

For some patients with severe or refractory SLE, B-cell depletion therapy, such as rituximab, has been used in clinical practice [5]. While rituximab has shown effectiveness in other autoimmune conditions like rheumatoid arthritis, it did not meet primary endpoints in two large randomized controlled trials for non-renal and renal SLE [5]. Experts suggest that factors such as trial design might have contributed to these results, and strategies like enhanced B-cell depletion or sequential therapy with other drugs like belimumab are being investigated to improve responses [5].

Given the systemic nature of SLE, monitoring for potential side effects of treatments is crucial. For instance, ophthalmologists play a role in monitoring for ocular toxicity associated with certain medications [1].

Living with SLE: Long-Term Considerations

Living with SLE involves ongoing management and attention to various aspects of health. Fatigue, a pervasive symptom, significantly impacts quality of life, and there is a recognized need for empirically based guidelines to manage it effectively [4].

For women with SLE, reproductive health is a key consideration. Obstetrician-gynecologists are essential in guiding patients on choices regarding birth control, managing pregnancy outcomes, understanding the risks of hormone therapy, and monitoring for lupus nephritis flares during pregnancy [2]. Additionally, women with SLE may have an increased concern for human papillomavirus (HPV) and associated cancers [2].

Early recognition and timely, comprehensive management are vital for preventing disease progression and achieving the best possible clinical outcomes for individuals with SLE [7]. Research continues to advance our understanding of the genetic and environmental factors influencing SLE, as well as the development of new diagnostic tools and therapeutic agents [1].

Sources

Systemic Lupus ErythematosusAutoimmune DiseaseLupus DiagnosisLupus TreatmentWomen's Health

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.